HIMS - Hims & Hers Health Inc.

Stock pulled back; if breaks under double bottom at $35.25, watch it down.

Listed as one of the eight incredible stocks picked by Felix and Winston. No specific analysis or current recommendation provided.

Listed as one of the incredible stocks picked by Felix and Winston.

Strong momentum play with a breakout point at $35.50. The stock performed well last week and is still trending strongly.

The hosts like HIMS for the long term and note strong short-term momentum. It recently broke past $32.50 resistance and has been trending higher with clear higher lows. Risk is market-wide selling.

HIMS is on the bullish radar, breaking a short-term downtrend and possibly a longer-term wedge. It's over 50% off its all-time high of $73 from January 2025. The speaker likes it for longer-term opportunity as the market transitions into risk-on mode. Watch resistance at $32-$32.50.

HIMS popped 12.5% today and is over 50% off its all-time high from February 2025. Host likes it for long term and sees short-term opportunity. Watching for breakout above $32 resistance, already breaking past $30. Increasing momentum.

Joe identifies HIMS as a potential short squeeze candidate if the FDA makes regulatory changes that could force short sellers to cover. He has been vocal about this setup.

Host calls HIMS a 'massive compounder' with 2.6M subscribers, 82% retention beyond 3 months, 59% revenue growth, and strong operating cash flow. He sees the current dip as temporary and outlines 5 catalysts: FDA peptide decision in July 2026, strong Q2 earnings expected, international business growing 10x, weight loss drug turnaround via Novo Nordisk deal, and a short squeeze setup with $1.72B short interest and insider buying. He says buyers in 5 years will be very happy.

Board member David Wells (former Netflix CFO) spent over $1M buying shares, increasing direct ownership by 27.5%. Stock is at lower end of range with nice trend of higher lows. Good risk-reward setup, especially if market continues ripping and investors go risk-on. Support around $22.